Jefferies Downgrades Ampio Pharmaceuticals To Hold

Analysts at Jefferies downgraded Ampio Pharmaceuticals AMPE from Buy to Hold. The target price for Ampio Pharmaceuticals has been lowered from $14 to $5. Ampio Pharmaceuticals shares have fallen 15.02% over the past 52 weeks, while the S&P 500 index has surged 19.77% in the same period. Ampio Pharmaceuticals' shares rose 0.71% to $5.70 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!